Bullish
Revvity Signals Software has joined Anthropic's directory for Model Context Protocol (MCP) connectors, allowing scientists to access Signals AI alongs...
Neutral
Shares of Revvity Inc. (RVTY) declined by 1.60% to $111.21 on Monday, marking its second consecutive day of losses. Despite this drop, the stock still...
Neutral
This article displays information related to the price-to-earnings forward metric for Revvity, Inc. (NYSE: RVTY). It indicates that the market was clo...
Neutral
This page from TradingView displays the "Price to sales forward" for Revvity, Inc. (PKN) on the Dusseldorf Stock Exchange. The core content focuses on...
Bullish
Revvity Inc. (RVTY) is trading higher on the NYSE with a consensus Buy rating from 11 Wall Street analysts. The stock is currently trading within a ra...
Neutral
Revvity is strategically expanding its Signals BioDesign software to enhance complex biologic research workflows, positioning itself in the life scien...
Alithea Genomics and Revvity Inc. have formed a strategic partnership to broaden the global availability of Alithea's MERCURIUS DRUG-seq and MERCURIUS...
Bullish
Revvity Inc. (RVTY) shares are trading below their 52-week high, generating mixed analyst opinions between "Hold" and "Buy" ratings. The company, focu...
Neutral
Revvity (RVTY) is divesting its China immunodiagnostics business, which represented about 6% of its revenue, to focus on higher-growth, higher-margin ...
Bullish
This article provides key financial data for Revvity, Inc. (PKN) from its balance sheet, highlighting the company's financial position as of Q1 2026. ...
Bullish
Revvity, Inc. (XETR:PKN) reported a free cash flow of 82.62 million EUR for Q1 2026. For the full year 2025, the company's free cash flow reached 43...